Structural Modification In Supraglottic Airway Device

NCT ID: NCT04498598

Last Updated: 2025-05-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-30

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed A/Z modification of a supraglottic airway (SGA) incorporates an opening in the SGA body that enables access to the endotracheal tube (ETT) through the body of the SGA without the need of using an exchange catheter, thus enabling an ETT to move in the body of the SGA and convert a supraglottic to endotracheal ventilation. In its original form an adaptor made from same material currently used in the endotracheal tubes can make ventilation through the proposed airway device possible in exactly the same manner of a conventional SGA currently used. This adapter also known as the R-piece can be replaced with an ETT. The modification also allows placement of SGA over an existing ETT to convert and endotracheal (ET) to supraglottic (SG) mode of ventilation without the need to use an exchange catheter.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The special design allows conversion of a telescopic coaxial portion (R piece), replacing with an ETT which can act coaxially to provide both supraglottic (up position) and endotracheal (down position) of ETT. See this modification in https://www.youtube.com/watch?v=iy84lALU1aI

Currently the proposed change to the conventional SGA has been made and feasibility tested on Manikins. The A/Z airway modification is also demonstrated in the attached link video https://www.youtube.com/watch?v=ukLOAC55iG8

In this study, we are trialing the A/Z concept on an original A/Z modification by a manufacturer on their currently used SGA. Thus instead of investigators making the changes by cutting a channel in a conventional SGA immediately before use in the Operating Room, they have asked a manufacturer to do so professionally.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Airway Complication of Anesthesia Ventilation Therapy; Complications Hypoxia Hypoventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A/Z Airway

Patients under general anesthesia for surgical procedures who need airway management for ventilation.

Group Type EXPERIMENTAL

A/Z Supraglottic airway

Intervention Type DEVICE

Patient receive supraglottic airway for general anesthesia which can be converted to endotracheal ventilation reversibly

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A/Z Supraglottic airway

Patient receive supraglottic airway for general anesthesia which can be converted to endotracheal ventilation reversibly

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult patients
2. scheduled for a general anesthesia procedure with ETT \& muscle relaxation

Exclusion Criteria

1. Patients who are not able to consent
2. Non English Speaking
3. History of difficult airway
4. Physical exam of airway which suggests difficulty in airway management or need to use special equipment
5. BMI \>35
6. Gastroesophageal reflux disease
7. Anesthetic plan other than general anesthesia
8. Emergency procedures
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cleveland Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rafi Avitsian, MD

Role: CONTACT

216-444-9735

Mark Mettler

Role: CONTACT

216-445-8281

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rafi Avitsian, MD

Role: primary

216-444-9735

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: Journal Abstracts

A. Varvinskiy, T. Hinde, 21st Annual Scientific Meeting of the Difficult Airway Society: lessons learned and glimpses of the future , BJA: British Journal of Anaesthesia, Volume 119, Issue 3, September 2017, Pages e31-e47,

View Document

Document Type: Journal Abstacts

J. Law, I. Morris, Historical cohort study of 10 288 tracheal intubations facilitated by video laryngoscopy, British Journal of Anaesthesia, Volume 121, Issue 1, 2018, Pages e1-e2, ISSN 0007-0912, https://doi.org/10.1016/j.bja.2018.02.037. (https://www.sciencedirect.com/science/article/pii/S0007091218301831)

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20-163

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.